第 1 到 16 筆結果,共 16 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2024 | Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations | FENG-MING TIEN ; CHI-YUAN YAO ; Tsai, Xavier Cheng-Hong; Lo, Min-Yen; Chen, Chien-Yuan; WAN-HSUAN LEE ; CHIEN-CHIN LIN ; Kuo, Yuan-Yeh; Peng, Yen-Ling; Tseng, Mei-Hsuan; Wu, Yu-Sin; Liu, Ming-Chih; LIANG-IN LIN ; MING-KAI CHUANG ; BOR-SHENG KO ; MING YAO ; Tang, Jih-Luh; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 0 | ||
2 | 2023 | Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification | WAN-HSUAN LEE ; Tsai, Ming-Tao; Tsai, Cheng-Hong; FENG-MING TIEN ; Lo, Min-Yen; Tseng, Mei-Hsuan; Kuo, Yuan-Yeh; Liu, Ming-Chih; YI-TSUNG YANG ; JUI-CHE CHEN ; JIH-LUH TANG ; Sun, Hsun-I; Chuang, Yi-Kuang; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-CHIN LIN ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 2 | 0 | |
3 | 2023 | Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia | Lo, Min-Yen; Tsai, Xavier Cheng-Hong; CHIEN-CHIN LIN ; FENG-MING TIEN ; Kuo, Yuan-Yeh; WAN-HSUAN LEE ; Peng, Yen-Ling; Liu, Ming-Chih; Tseng, Mei-Hsuan; Hsu, Cheng-An; JUI-CHE CHEN ; LIANG-IN LIN ; Sun, Hsun-I; Chuang, Yi-Kuang; BOR-SHENG KO ; JIH-LUH TANG ; MING YAO ; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | American journal of hematology | 6 | 4 | |
4 | 2023 | Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML | CHENG-HONG TSAI ; Sun, Kuo-Jui; Lo, Min-Yen; FENG-MING TIEN ; YUAN-YEH KUO ; Tseng, Mei-Hsuan; Peng, Yen-Ling; Chuang, Yi-Kuang; BOR-SHENG KO ; JIH-LUH TANG ; Sun, Hsun-I; Liu, Ming-Chih; CHIA-WEN LIU ; CHIEN-CHIN LIN ; MING YAO ; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood cancer journal | 7 | 3 | |
5 | 2023 | Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification | WAN-HSUAN LEE ; CHIEN-CHIN LIN ; CHENG-HONG TSAI ; FENG-MING TIEN ; Lo, Min-Yen; Ni, Sao-Chih; MING YAO ; Tseng, Mei-Hsuan; YUAN-YEH KUO ; Liu, Ming-Chih; JIH-LUH TANG ; Sun, Hsun-I; Chuang, Yi-Kuang; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | American journal of hematology | 4 | 3 | |
6 | 2022 | Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes | WAN-HSUAN LEE ; CHIEN-CHIN LIN ; Wang, Yu-Hung; CHI-YUAN YAO ; Kuo, Yuan-Yeh; Tseng, Mei-Hsuan; Peng, Yen-Ling; Hsu, Cheng-An; Sun, Hsun-I; Chuang, Yi-Kuang; Hsu, Chia-Lang; FENG-MING TIEN ; Tsai, Cheng-Hong; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Hematological oncology | 0 | 0 | |
7 | 2022 | Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience | Wang, Yu-Wen; Tsai, Cheng-Hong ; HSIN-AN HOU ; FENG-MING TIEN ; JIA-HAU LIU ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Chen, Yu-Wen; CHIEN-CHIN LIN ; Chieh-Lung Cheng ; Lo, Min-Yen; YUN-CHU LIN ; LI-CHUN LU ; SHANG-JU WU ; SUNG-HSIN KUO ; RUEY-LONG HONG ; TAI-CHUNG HUANG ; MING YAO | Annals of hematology | 10 | 9 | |
8 | 2022 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | FENG-MING TIEN ; CHENG-HONG TSAI ; Huang, Sheng-Chuan; JIA-HAU LIU ; Chen, Chien-Yuan ; YUAN-YEH KUO ; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; CHIA-WEN LIU ; Liao, Xiu-Wen; LIANG-IN LIN ; Wu, Yu-Sin; Hou, Mei-Fang; SHANG-JU WU ; SZU-CHUN HSU ; BOR-SHENG KO ; WEN-CHIEN CHOU ; MING YAO ; HSIN-AN HOU ; JIH-LUH TANG ; HWEI-FANG TIEN | Bone marrow transplantation | 6 | 6 | |
9 | 2021 | Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML | CHENG-HONG TSAI ; JIH-LUH TANG ; FENG-MING TIEN ; YUAN-YEH KUO ; Wu D.-C.; CHIEN-CHIN LIN ; Tseng M.-H.; Peng Y.-L.; Hou M.-F.; Chuang Y.-K.; Liu M.-C.; CHIA-WEN LIU ; MING YAO ; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-YU CHEN ; HSIN-AN HOU ; HWEI-FANG TIEN | Blood Advances | 32 | 27 | |
10 | 2020 | Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax | Wang, Yu-Wen; CHENG-HONG TSAI ; CHIEN-CHIN LIN ; FENG-MING TIEN ; Chen, Yu-Wen; HSIN-YI LIN ; MING YAO ; YUN-CHU LIN ; Lin, Chien-Ting; Chieh-Lung Cheng ; JIH-LUH TANG ; WEN-CHIEN CHOU ; HSIN-AN HOU ; HWEI-FANG TIEN | Annals of hematology | 52 | 53 | |
11 | 2020 | ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden | Wang Y.-H.; CHIEN-CHIN LIN ; Lee S.-H.; CHENG-HONG TSAI ; Wu S.-J.; HSIN-AN HOU ; TAI-CHUNG HUANG ; Kuo Y.-Y.; MING YAO ; Chang K.; CHUNG-WU LIN ; YUN-CHU LIN ; FENG-MING TIEN ; WEN-CHIEN CHOU ; JIH-LUH TANG ; HWEI-FANG TIEN | Blood Cancer Journal | 6 | 6 | |
12 | 2019 | Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients | CHENG-HONG TSAI ; CHI-YUAN YAO ; FENG-MING TIEN ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chiu, Yu-Chiao; CHIEN-CHIN LIN ; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; MING YAO ; LIANG-IN LIN ; WEN-CHIEN CHOU ; CHIEN-YU CHEN ; HSIN-AN HOU ; HWEI-FANG TIEN | EBioMedicine | 21 | 22 | |
13 | 2018 | Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Li, Chi-Cheng; Lin, Chien-Ting; MING YAO ; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | European Journal of Haematology | 29 | 23 | |
14 | 2018 | Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA | FENG-MING TIEN ; HSIN-AN HOU ; JIH-LUH TANG ; Kuo, Yuan-Yeh; Chen, Chien-Yuan ; CHENG-HONG TSAI ; MING YAO ; Lin, Chien-Ting; Li, Chi-Cheng; SHANG-YI HUANG ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-JU WU ; JIA-HAU LIU ; SHENG-CHIEH CHOU ; WOEI TSAY ; Tseng, Mei-Hsuan; Liu, Ming-Chih; Liu, Chia-Wen; LIANG-IN LIN ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Haematologica | 25 | 21 | |
15 | 2018 | GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia | FENG-MING TIEN ; HSIN-AN HOU ; CHENG-HONG TSAI ; JIH-LUH TANG ; Chiu, Yu-Chiao; Chen, Chien-Yuan ; Kuo, Yuan-Yeh; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; LIANG-IN LIN ; Lin, Chien-Ting; SHANG-JU WU ; BOR-SHENG KO ; SZU-CHUN HSU ; SHANG-YI HUANG ; MING YAO ; WEN-CHIEN CHOU ; HWEI-FANG TIEN | Blood Cancer Journal | 29 | ||
16 | 2018 | Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan | Chen, Chien-Yuan ; FENG-MING TIEN ; ARISTINE CHENG ; SHANG-YI HUANG ; WEN-CHIEN CHOU ; MING YAO ; JIH-LUH TANG ; HWEI-FANG TIEN ; WANG-HUEI SHENG | BMC Gastroenterology | 23 | 23 |